DR Horton Share Price

Equities

DHI

US23331A1097

Homebuilding

Real-time Estimate Cboe BZX 18:55:33 15/05/2024 BST 5-day change 1st Jan Change
156.6 USD +5.78% Intraday chart for DR Horton +5.75% +2.80%
Sales 2024 * 36.93B 2,916B Sales 2025 * 39.42B 3,113B Capitalization 48.74B 3,849B
Net income 2024 * 4.72B 373B Net income 2025 * 5B 395B EV / Sales 2024 * 1.36 x
Net Debt 2024 * 1.36B 108B Net Debt 2025 * 1.02B 80.58B EV / Sales 2025 * 1.26 x
P/E ratio 2024 *
10.4 x
P/E ratio 2025 *
9.51 x
Employees 13,450
Yield 2024 *
0.81%
Yield 2025 *
0.87%
Free-Float 73.76%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.11%
1 week+4.22%
Current month+8.06%
1 month+3.29%
3 months+5.91%
6 months+20.39%
Current year+1.31%
More quotes
1 week
146.41
Extreme 146.41
154.99
1 month
140.00
Extreme 140
154.99
Current year
138.83
Extreme 138.83
165.75
1 year
100.08
Extreme 100.08
165.75
3 years
59.25
Extreme 59.25
165.75
5 years
25.51
Extreme 25.51
165.75
10 years
19.29
Extreme 19.29
165.75
More quotes
Managers TitleAgeSince
Founder 74 31/12/77
Chief Executive Officer 54 31/12/98
Director of Finance/CFO 58 31/12/97
Members of the board TitleAgeSince
Founder 74 31/12/77
Director of Finance/CFO 58 31/12/97
Director/Board Member 78 22/01/14
More insiders
Date Price Change Volume
15/05/24 156.2 +5.55% 2 130 379
14/05/24 148 +0.78% 1,914,058
13/05/24 146.9 -2.07% 2,845,332
10/05/24 150 +0.31% 2,085,630
09/05/24 149.5 +1.19% 4,055,035

Delayed Quote Nyse, May 15, 2024 at 04:41 pm

More quotes
D.R. Horton, Inc. is one of the leading American single-family homebuilders. Net sales break down by activity as follows: - construction of single-family homes and development of lots (90.4%): home sales (detached homes, attached homes, etc.; operating under the names D.R. Horton, America's Builder, Emerald Homes, Express Homes, Freedom Homes and Pacific Ridge Homes) and lot sales; - property rental (7.3%); - supply of financial services (2.3%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
148 USD
Average target price
170.4 USD
Spread / Average Target
+15.11%
Consensus